These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 21707225

  • 1. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
    Durmaz O, Demirkaya M, Sevinir B.
    Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
    [Abstract] [Full Text] [Related]

  • 2. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M, Leonard RC, Barnadas A, Marangolo M, Untch M, Malamos N, Mayordomo J, Reichert D, Pedrini JL, Ukarma L, Scherhag A, Burger HU.
    J Clin Oncol; 2008 Feb 01; 26(4):592-8. PubMed ID: 18235117
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A.
    Pediatr Hematol Oncol; 2008 Sep 01; 25(6):509-21. PubMed ID: 18728970
    [Abstract] [Full Text] [Related]

  • 4. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.
    Oncologist; 2006 Feb 01; 11(2):206-16. PubMed ID: 16476841
    [Abstract] [Full Text] [Related]

  • 5. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N, Fouda M.
    Hematology; 2007 Dec 01; 12(6):533-41. PubMed ID: 17852440
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.
    Waltzman R, Croot C, Justice GR, Fesen MR, Charu V, Williams D.
    Oncologist; 2005 Sep 01; 10(8):642-50. PubMed ID: 16177289
    [Abstract] [Full Text] [Related]

  • 7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N, Sriuranpong V, Suwanrusme H.
    J Med Assoc Thai; 2007 Jun 01; 90(6):1082-8. PubMed ID: 17624200
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
    Desai J, Demetri GD.
    Best Pract Res Clin Haematol; 2005 Jun 01; 18(3):389-406. PubMed ID: 15792913
    [Abstract] [Full Text] [Related]

  • 9. Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.
    Ots PM, Pérez AR, Carrizosa CL, Ocaña CV, de Dios Sáez Garrido J, Delgado Pérez JM.
    Clin Transl Oncol; 2005 Dec 01; 7(11):486-92. PubMed ID: 16373059
    [Abstract] [Full Text] [Related]

  • 10. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 May 01; 88(5):607-12. PubMed ID: 16149676
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.
    Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR.
    J Clin Oncol; 2006 Aug 01; 24(22):3583-9. PubMed ID: 16877725
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN, Chaidos A, Gouva M, Christou L, Panteli K, Kapsali E, Bourantas KL.
    J Exp Clin Cancer Res; 2004 Mar 01; 23(1):47-52. PubMed ID: 15149150
    [Abstract] [Full Text] [Related]

  • 13. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
    Nampoory MR, Johny KV, al-Hilali N, Seshadri MS, Kanagasabhapathy AS.
    Nephrol Dial Transplant; 1996 Jan 01; 11(1):177-81. PubMed ID: 8649630
    [Abstract] [Full Text] [Related]

  • 14. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov 01; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 15. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct 01; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 16. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun 01; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 17. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
    León Molinari P, Jiménez Monteagudo M, Barona Zamora P, Riol Diego M, Castro Paz L, Sierrasesúmaga Ariznavarreta L.
    An Esp Pediatr; 1998 Jul 01; 49(1):17-22. PubMed ID: 9718761
    [Abstract] [Full Text] [Related]

  • 18. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D, George MJ, Harrison LB.
    Cancer; 2003 Sep 01; 98(5):1072-9. PubMed ID: 12942577
    [Abstract] [Full Text] [Related]

  • 19. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
    Granetto C, Ricci S, Martoni A, Pezzella G, Testore F, Mattioli R, Lampignano M, Tacconi F, Porrozzi S, Gasparini G, Mantovani G, EPO-ITA3 Study Group.
    Oncol Rep; 2003 Sep 01; 10(5):1289-96. PubMed ID: 12883695
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E, Madeddu C, Lusso MR, Gramignano G, Mantovani G.
    Crit Rev Oncol Hematol; 2006 Feb 01; 57(2):175-82. PubMed ID: 16213740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.